These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4633166)

  • 1. Determination of serum properdin levels by immunodiffusion.
    Westberg NG; McLean RH; Michael AF
    Int Arch Allergy Appl Immunol; 1973; 44(1):155-60. PubMed ID: 4633166
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative measurement of properdin in normal human serum by electroimmunoassay and single radial immunodiffusion.
    Persson K; Kindmark CO; Pensky J; Naff G
    Clin Exp Immunol; 1977 Jul; 29(1):84-8. PubMed ID: 408067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of human properdin using anti-human erythrocyte guinea pig serum].
    DIACONO H; CASTAY M
    C R Seances Soc Biol Fil; 1958; 152(10):1346-9. PubMed ID: 13629992
    [No Abstract]   [Full Text] [Related]  

  • 4. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S; Fearon DT; Austen KF
    Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion.
    Finberg R; Barland P; Grayzel AI
    Am J Clin Pathol; 1977 Jan; 67(1):97-9. PubMed ID: 401557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
    [No Abstract]   [Full Text] [Related]  

  • 7. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    Clin Exp Immunol; 1974 Apr; 16(4):575-81. PubMed ID: 4219766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properdin factor D. II. Activation to D by properdin.
    Fearon DT; Austen KF; Ruddy S
    J Exp Med; 1974 Aug; 140(2):426-36. PubMed ID: 4211020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properdin determination in human sera.
    BIANCHI V; GHIRARDO G; SANGUINETI M
    Acta Haematol; 1959 May; 21(5):295-300. PubMed ID: 13660749
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Properdin, factor H, factor I].
    Ohsawa I; Tomino Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():77-81. PubMed ID: 20942006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin].
    SCHEIFFARTH F; FRENGER W; GOTZ H
    Klin Wochenschr; 1958 Apr; 36(8):367-9. PubMed ID: 13550834
    [No Abstract]   [Full Text] [Related]  

  • 15. The determination of 1 C-globulin (C' 3 component of complement) by immunodiffusion in various clinical states of bronchial asthma.
    Chachaj W; Szott M; Falowska-Adamczyk W
    Pol Med J; 1972; 11(2):320-5. PubMed ID: 4627218
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum-properdin levels in patients with Hodgkin's disease and carcinoma.
    ROTTINO A; LEVY AL
    Cancer; 1957; 10(5):877-83. PubMed ID: 13472632
    [No Abstract]   [Full Text] [Related]  

  • 17. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement system studies in systemic lupus erythematosus (SLE).
    Teisberg P
    Acta Med Scand; 1975; 197(1-2):131-4. PubMed ID: 47697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic properdin determination. II. Properdin determination in human serum by a modified time-saving procedure according to Fritzsche, Fischer, Schwick and Schultze].
    Harm M
    Arch Exp Veterinarmed; 1965 Apr; 19(1):395-8. PubMed ID: 5833345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.